🇺🇸 FDA
Patent

US 10858410

Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier

granted A61KA61K38/00A61P

Quick answer

US patent 10858410 (Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61P, A61P25/02